- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/36 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 241/36
Total number of patents in this class: 181
10-year publication summary
|
10
|
9
|
7
|
8
|
12
|
8
|
10
|
7
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Agios Pharmaceuticals, Inc | 216 |
7 |
| Merck Sharp & Dohme LLC | 3724 |
7 |
| Idemitsu Kosan Co., Ltd. | 4129 |
6 |
| Otsuka Pharmaceutical Co., Ltd. | 1493 |
5 |
| Merck Sharp & Dohme Corp. | 2202 |
4 |
| Bristol-myers Squibb Company | 4848 |
3 |
| Japan Science and Technology Agency | 1365 |
3 |
| Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | 328 |
3 |
| Intra-Cellular Therapies, Inc. | 402 |
3 |
| Kyushu University, National University Corporation | 1637 |
3 |
| Janssen Pharmaceutica N.V. | 3436 |
2 |
| Pfizer Inc. | 3331 |
2 |
| Semiconductor Energy Laboratory Co., Ltd. | 11245 |
2 |
| Samsung SDI Co., Ltd. | 7706 |
2 |
| California Institute of Technology | 3953 |
2 |
| Board of Regents, The University of Texas System | 5689 |
2 |
| The Regents of the University of Michigan | 4620 |
2 |
| Millennium Pharmaceuticals, Inc. | 463 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2121 |
2 |
| DIC Corporation | 3720 |
2 |
| Other owners | 117 |